Trials / Completed
CompletedNCT02571907
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
Clinical Study to Evaluate the Safety and Effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Cook Research Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Zenith® Branch Endovascular Graft-Iliac Bifurcation, | Implantation of the Zenith® Branch Endovascular Graft-Iliac Bifurcation. |
| DEVICE | Atrium iCAST™ | Implantation of Atrium iCAST |
| DEVICE | Zenith® Flex AAA Endovascular Graft | Implantation of the Zenith Flex Endovascular Graft |
Timeline
- Start date
- 2014-04-01
- Primary completion
- 2015-11-01
- Completion
- 2020-11-04
- First posted
- 2015-10-08
- Last updated
- 2025-07-16
- Results posted
- 2025-07-16
Locations
28 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02571907. Inclusion in this directory is not an endorsement.